TIPE2 upregulation in human NSCLC tissues was negatively associated with the primary tumor size, lymph node metastasis, and advanced clinical stage, which can be used to predict lymph node metastasis. Here, TIPE2 is linked to metastatic malignant neoplasm in the lymph nodes.